Dilemas nutricionais no pré-termo extremo e repercussões na infância, adolescência e vida adulta

Camelo, José Simon; Martinez, Francisco Eulógio

doi:10.1590/s0021-75572005000200005

Cited by 10 publications

(2 citation statements)

References 87 publications

(104 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Epidemiologic evidence shows that early nutrition and growth in preterm infants influence their development of diseases later in life, as well as their neurodevelopmental outcomes192021). This study provides recent data on the postnatal growth of VLBW infants from birth to PCA 24 months in Korea.…”

Section: Discussionmentioning

confidence: 81%

Postdischarge growth assessment in very low birth weight infants

et al. 2017

View full text Add to dashboard Cite

PurposeThe goal of nutritional support for very-low-birth-weight (VLBW) infants from birth to term is to match the in utero growth rates; however, this is rarely achieved.MethodsWe evaluated postdischarge growth patterns and growth failure in 81 Korean VLBW infants through a retrospective study. Weight and height were measured and calculated based on age percentile distribution every 3 months until age 24 months. Growth failure was defined as weight and height below the 10th percentile at 24 months. For the subgroup analysis, small-for-gestational age (SGA) and extremely low birth weight (ELBW) infants were evaluated. The growth patterns based on the Korean, World Health Organization (WHO), or Centers for Disease Control and Prevention (CDC) standard were serially compared over time.ResultsAt postconception age (PCA) 40 weeks, 47 (58%) and 45 infants (55%) showed growth failure in terms of weight and height, respectively. At PCA 24 months, 20 infants (24%) showed growth failure for weight and 14 (18%) for height. Growth failure rates were higher for the SGA infants than for the appropriate-weight-for-gestational age infants at PCA 24 months (P=0.045 for weight and P=0.038 for height). Growth failure rates were higher for the ELBW infants than for the non-ELBW infants at PCA 24 months (P<0.001 for weight and P=0.003 for height). Significant differences were found among the WHO, CDC, and Korean standards (P<0.001).ConclusionAdvancements in neonatal care have improved the catch-up growth of VLBW infants, but this is insufficient. Careful observation and aggressive interventions, especially in SGA and ELBW infants, are needed.

show abstract

Section: Discussionmentioning

confidence: 81%

Postdischarge growth assessment in very low birth weight infants

et al. 2017

View full text Add to dashboard Cite

show abstract

“…A introdução de aminoácidos precocemente, o uso de soluções de lipídios adequadas, o conceito de nutrição enteral mínima e a adequação de micronutrientes (vitaminas, oligoelementos e minerais) têm melhorado a sobrevida, em especial, de recém-nascidos pré-termo de muito baixo peso (RNMBP), contribuindo para diminuir a permanência hospitalar, além de evitar as doenças crônicas não transmissíveis em longo prazo 1,2 .…”

Section: Introductionunclassified

Comparison between homologous human milk supplements and a commercial supplement for very low birth weight infants

et al. 2012

View full text Add to dashboard Cite

Objectives: To describe the methodology for the preparation of two additives derived from human milk, liquid and powdered, and to compare this composition with the commercial additive FM85 ® . Methods:For the preparation of the liquid and powdered supplements, 40 samples of human milk were used. Both supplements have been through three preparation phases: skimming, evaporation and lactose removal. After these phases, the liquid supplement is ready, and the powdered requires a fourth phase -lyophilization. To each sample of the liquid and powdered supplements were added, respectively, 80 mL (group I) and 100 mL (group II) of pooled banked human milk. For comparison, 20 samples of 100 mL of the pool were added to 5 g of the FM85 ® supplement (Nestlé) (group III). Analyses of carbohydrates, protein, lipids, calcium, phosphorus, sodium, osmolality and caloric content were performed, considering a significant difference p < 0.05. Results Conclusion:The studied additives differ significantly from the commercial additive FM85 ® in some of its components, and its composition may or may not meet the quantity of nutrients suggested by the most recent recommendations. J Pediatr (Rio J). 2012;88(2):119-24:Premature infant, enteral nutrition, human milk, milk bank. ResumoObjetivos: Descrever a metodologia de preparo de dois aditivos, líquido e em pó, derivados do leite humano e comparar a constituição com aditivo comercial FM85 ® . Métodos:Foram utilizadas 40 amostras de leite humano para o preparo dos suplementos líquido e em pó. Ambos passaram por três fases de preparo: desnate, evaporação e retirada da lactose. Após essas fases, o suplemento líquido está pronto, e o em pó necessita da quarta fase -a liofilização. Em cada amostra dos suplementos líquido e em pó, foram adicionados, respectivamente, 80 mL (grupo I) e 100 mL (grupo II) de pool de leite humano de banco. Para comparação, 20 amostras de 100 mL do pool foram acrescidas de 5 g do suplemento FM85 ® (Nestlé) (grupo III). Realizaram-se análises de hidratos de carbono, proteína, lipídios, cálcio, fósforo, sódio, osmolalidade e conteúdo calórico, considerando diferença significativa p < 0,05. Conclusão:Os aditivos estudados diferem significativamente do aditivo comercial FM85 ® em alguns de seus constituintes, e a sua constituição pode ou não atender às quantidades de nutrientes propostas pelas recomendações mais recentes. J Pediatr (Rio J)

show abstract